XML 36 R18.htm IDEA: XBRL DOCUMENT
v3.22.4

Stockholders’ Equity (Tables) | 9 Months Ended
--- | ---
Dec. 31, 2022
Stockholders' Equity Note [Abstract] |
Schedule of analysis of option activity | Options outstanding and exercisable under the 2000 Plan are as follows:
|  | As of December 31, 2022: |
Range of Prices |  | Options Outstanding and Exercisable |  |  | Weighted Average Remaining Life in Years |  |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value (In thousands) |
$1.16 - $7.40 |  |  | 5,000 |  |  |  | 2.50 |  |  | $ | 7.40 |  |  | $ | — |
$13.70 - $24.40 |  |  | 207,037 |  |  |  | 0.78 |  |  |  | 14.63 |  |  |  | — |
|  |  | 212,037 |  |  |  | 0.82 |  |  | $ | 14.46 |  |  | $ | — |
|  | As of March 31, 2022: |
Range of Prices |  | Options Outstanding and Exercisable |  |  | Weighted Average Remaining Life in Years |  |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value (In thousands) |
$7.40 |  |  | 5,000 |  |  |  | 3.25 |  |  | $ | 7.40 |  |  | $ | — |
$14.00 - $24.40 |  |  | 212,337 |  |  |  | 1.50 |  |  |  | 14.65 |  |  |  | — |
|  |  | 217,337 |  |  |  | 1.54 |  |  | $ | 14.49 |  |  | $ | — |
Schedule of stock appreciation rights outstanding |
|  | As of December 31, 2022: |
Range of Prices |  | SARs Outstanding |  |  | Weighted Average Remaining Life in Years |  |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value (In thousands) |
$0.33 - $0.74 |  |  | 8,650,000 |  |  |  | 8.61 |  |  | $ | 0.56 |  |  | $ | — |
$1.16 - $1.47 |  |  | 2,128,277 |  |  |  | 6.55 |  |  |  | 1.39 |  |  |  | — |
$1.71 - $2.10 |  |  | 2,237,493 |  |  |  | 8.36 |  |  |  | 1.92 |  |  |  | — |
$2.23 - $2.56 |  |  | 455,583 |  |  |  | 8.81 |  |  |  | 2.28 |  |  |  | — |
|  |  | 13,471,353 |  |  |  |  |  |  |  |  | $ | — |
|  | As of March 31, 2022: |
Range of Prices |  | SARs Outstanding |  |  | Weighted Average Remaining Life in Years |  |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value (In thousands) |
$0.54 - $0.74 |  |  | 5,550,000 |  |  |  | 8.74 |  |  | $ | 0.62 |  |  | $ | 1,208 |
$1.16 - $1.47 |  |  | 2,283,610 |  |  |  | 7.90 |  |  |  | 1.37 |  |  |  | — |
$1.71 - $2.10 |  |  | 2,455,738 |  |  |  | 8.91 |  |  |  | 1.97 |  |  |  | — |
$2.23 - $2.56 |  |  | 604,250 |  |  |  | 9.60 |  |  |  | 2.32 |  |  |  | — |
|  |  | 10,893,598 |  |  |  |  |  |  |  |  | $ | 1,208 |
An analysis of all SARs exercisable under the 2017 Plan as of December 31, 2022 is presented below:
SARs Exercisable |  |  | Weighted Average Remaining Life in Years |  |  | Weighted Average Exercise Price |  |  | Aggregate Intrinsic Value (In thousands) |
| 5,448,345 |  |  |  | 7.75 |  |  | $ | 1.13 |  |  | $ | — |
Schedule of SARs outstanding |
|  | Nine Months Ended December 31, 2022 |
SARs Outstanding - March 31, 2022 |  |  | 10,893,598 |
Issued |  |  | 3,100,000 |
Forfeited |  |  | (522,245 | )
Total SARs Outstanding - December 31, 2022 |  |  | 13,471,353 |
Schedule of weighted average assumptions used to estimate fair value of SARs | The following weighted average assumptions were used to estimate the fair value of SARs granted as follows:
|  | Nine Months Ended December 31, 2022 |
Expected dividend yield |  |  | — |
Expected equity volatility |  |  | 111.89 | %
Expected term (years) |  |  | 6.50 |
Risk-free interest rate |  |  | 4.49 | %
Exercise price |  | $ | 0.49 |
Market price per share |  | $ | 0.49 |
Weighted average fair value per SAR |  | $ | 0.43 |
Schedule of stock-based compensation expense |
|  | Three Months Ended December 31, |  |  | Nine Months Ended December 31, |
|  | 2022 |  |  | 2021 |  |  | 2022 |  |  | 2021 |
Selling, general and administrative |  | $ | 708 |  |  | $ | 1,349 |  |  | $ | 3,906 |  |  | $ | 3,278 |

X
- Definition Tabular disclosure of SARs outstanding. + References No definition available. + Details
Name: | cidm_ScheduleOfSARsOutstandingTableTextBlock
Namespace Prefix: | cidm_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of employee stock purchase plan activity. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (g) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationEmployeeStockPurchasePlanActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of option exercise prices, by grouped ranges, including the upper and lower limits of the price range, the number of shares under option, weighted average exercise price and remaining contractual option terms. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationSharesAuthorizedUnderStockOptionPlansByExercisePriceRangeTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the number and weighted-average exercise prices (or conversion ratios) for stock options and stock appreciation rights that were outstanding at the beginning and end of the year, exercisable at the end of the year, and the number of stock options and stock appreciation rights that were granted, exercised or converted, forfeited, and expired during the year. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedCompensationStockOptionsAndStockAppreciationRightsAwardActivityTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the significant assumptions used during the year to estimate the fair value of stock options, including, but not limited to: (a) expected term of share options and similar instruments, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI https://asc.fasb.org/extlink&oid=128089324&loc=d3e5070-113901 + Details
Name: | us-gaap_ScheduleOfShareBasedPaymentAwardStockOptionsValuationAssumptionsTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration